1. "2017"
  2. "Sean Devlin"
  3. "MSK Grad Students"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (7)
Groups
  1. Biostatistics Service (19)
  2. Center for Hematologic Malignancies (19)
  3. Department of Medicine (19)
  4. Epidemiology and Biostatistics (19)
  5. Hematologic Malignancies, Division of (19)
  6. MSK Grad Students (19)

More Groups

People
  1. Sean Devlin (19)
  2. Sergio Giralt (18)
  3. Miguel-Angel Perales (15)
  4. Molly Maloy (13)
  5. Roni Tamari (13)
  6. Guenther Koehne (12)

More People

Years
  1. 2017 (19)
Publications
  1. Biology of Blood and Marrow Transplantation (12)
  2. Blood (4)
  3. Bone Marrow Transplantation (1)
  4. Journal of Clinical Oncology (1)
  5. Nature Medicine (1)
Publishers
  1. Elsevier Inc. (12)
  2. American Society of Hematology (4)
  3. Nature Publishing Group (2)
  4. American Society of Clinical Oncology (1)

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toxicities and outcomes in the first year after ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies
    Meeting Abstract

    Kosuri, S.; Herrera, D. A. A.; Scordo, M.; Shah, G. L.; Devlin, S. M.; Maloy, M.; Nieves, J.; Cho, C.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Post-transplant toxicities and outcomes in long-term survivors of ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Graft-versus host disease (GVHD status and severity mediate late effects of allogeneic hematopoietic stem cell transplantation (HSCT) in a 1-year landmark analysis
    Meeting Abstract

    Sola, M.; Devlin, S. M.; Maloy, M.; Dierov, D.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Incidence, severity, day 100 treatment efficacy and therapy toxicity of cytomegalovirus (CMV) infections with early pre-emptive therapy in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Lau, C.; Bhatt, V.; Dahi, P.; Devlin, S. M.; Yoo, Y.; Adel, N. G.; Mazis, C.; Perales, M. A.; Giralt, S. A.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A novel intermediate intensity conditioning regimen achieves high rates of long-term outpatient progression-free survival offsetting the disadvantage of early post-transplant complications in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M.; Scaradavou, A.; Dahi, P.; Perales, M. A.; Giralt, S. A.; Ponce, D. M.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Immune-mediated hemolytic anemia (IMHA) and immune thrombocytopenia (ITP) after ex-vivo CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Adrianzen Herrera, D. A.; Hsu, M.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Despite increasing size of unrelated donor (URD) registries and the global CB inventory racial disparities in access to URD and CB grafts persist: A prospective 10 year analysis of 1,112 patients
    Meeting Abstract

    Boughan, K. M.; Dahi, P.; Devlin, S. M.; Byam, C.; Yoo, Y.; Mazis, C.; Davis, E.; Nhaissi, M.; Paulson, J.; Wells, D. S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival with organ toxicity predicting for overall survival (OS) and non-relapse mortality (NRM) in older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation (Allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Adrianzen Herrera, D. A.; Cho, C.; Maloy, M.; Nieves, J.; Devlin, S. M.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
    Blood (2017)

    Fulltext@MSK | Save